American Cannabis Competitors

Innovative Industrial Properties (NYSE:IIPR) and American Cannabis (OTCMKTS:AMMJ) are both finance companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, risk, valuation, earnings, analyst recommendations, profitability and dividends.

Profitability

This table compares Innovative Industrial Properties and American Cannabis' net margins, return on equity and return on assets.

Analyst Ratings

This is a summary of current ratings and target prices for Innovative Industrial Properties and American Cannabis, as reported by MarketBeat.

Innovative Industrial Properties currently has a consensus price target of $192.4286, indicating a potential upside of 10.76%. Given Innovative Industrial Properties' higher probable upside, equities analysts clearly believe Innovative Industrial Properties is more favorable than American Cannabis.

Valuation & Earnings

This table compares Innovative Industrial Properties and American Cannabis' top-line revenue, earnings per share (EPS) and valuation.

Innovative Industrial Properties has higher revenue and earnings than American Cannabis.

Institutional & Insider Ownership

74.9% of Innovative Industrial Properties shares are owned by institutional investors. 2.9% of Innovative Industrial Properties shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Innovative Industrial Properties beats American Cannabis on 8 of the 8 factors compared between the two stocks.

GrowGeneration (NASDAQ:GRWG) and American Cannabis (OTCMKTS:AMMJ) are both basic materials companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, risk, valuation, earnings, analyst recommendations, profitability and dividends.

Profitability

This table compares GrowGeneration and American Cannabis' net margins, return on equity and return on assets.

Analyst Ratings

This is a summary of current ratings and target prices for GrowGeneration and American Cannabis, as reported by MarketBeat.

GrowGeneration currently has a consensus price target of $49.5714, indicating a potential upside of 22.70%. Given GrowGeneration's higher probable upside, equities analysts clearly believe GrowGeneration is more favorable than American Cannabis.

Valuation & Earnings

This table compares GrowGeneration and American Cannabis' top-line revenue, earnings per share (EPS) and valuation.

GrowGeneration has higher revenue and earnings than American Cannabis.

Institutional & Insider Ownership

51.3% of GrowGeneration shares are owned by institutional investors. 13.6% of GrowGeneration shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

GrowGeneration beats American Cannabis on 8 of the 8 factors compared between the two stocks.

22nd Century Group (NYSEAMERICAN:XXII) and American Cannabis (OTCMKTS:AMMJ) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, risk, valuation, earnings, analyst recommendations, profitability and dividends.

Valuation & Earnings

This table compares 22nd Century Group and American Cannabis' top-line revenue, earnings per share (EPS) and valuation.

Analyst Ratings

This is a summary of current ratings and target prices for 22nd Century Group and American Cannabis, as reported by MarketBeat.

Profitability

This table compares 22nd Century Group and American Cannabis' net margins, return on equity and return on assets.

Summary

22nd Century Group beats American Cannabis on 1 of the 1 factors compared between the two stocks.

American Cannabis (OTCMKTS:AMMJ) and NSAV (OTCMKTS:NSAV) are both industrials companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, profitability, risk, analyst recommendations, dividends, earnings and institutional ownership.

Earnings & Valuation

This table compares American Cannabis and NSAV's top-line revenue, earnings per share and valuation.

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for American Cannabis and NSAV, as provided by MarketBeat.com.

Profitability

This table compares American Cannabis and NSAV's net margins, return on equity and return on assets.

American Cannabis (OTCMKTS:AMMJ) and KushCo (OTCMKTS:KSHB) are both industrials companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, profitability, risk, analyst recommendations, dividends, earnings and institutional ownership.

Insider and Institutional Ownership

0.0% of KushCo shares are owned by institutional investors. 17.3% of KushCo shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Earnings & Valuation

This table compares American Cannabis and KushCo's top-line revenue, earnings per share and valuation.

American Cannabis has higher earnings, but lower revenue than KushCo.

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for American Cannabis and KushCo, as provided by MarketBeat.com.

KushCo has a consensus target price of $1.8750, indicating a potential upside of 48.81%. Given KushCo's higher possible upside, analysts clearly believe KushCo is more favorable than American Cannabis.

Profitability

This table compares American Cannabis and KushCo's net margins, return on equity and return on assets.

Summary

KushCo beats American Cannabis on 5 of the 8 factors compared between the two stocks.

American Cannabis (OTCMKTS:AMMJ) and Terra Tech (OTCMKTS:TRTC) are both industrials companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, profitability, risk, analyst recommendations, dividends, earnings and institutional ownership.

Insider and Institutional Ownership

0.1% of Terra Tech shares are owned by institutional investors. 6.7% of Terra Tech shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Earnings & Valuation

This table compares American Cannabis and Terra Tech's top-line revenue, earnings per share and valuation.

American Cannabis has higher earnings, but lower revenue than Terra Tech.

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for American Cannabis and Terra Tech, as provided by MarketBeat.com.

Profitability

This table compares American Cannabis and Terra Tech's net margins, return on equity and return on assets.